Literature DB >> 8051429

Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.

C L Shovlin1, H A Simmonds, L D Fairbanks, S J Deacock, J M Hughes, R I Lechler, A D Webster, X M Sun, J C Webb, A K Soutar.   

Abstract

Adenosine deaminase (ADA) deficiency is identified here as a cause of adult onset immunodeficiency. Two sisters who noted recurrent, predominantly chest infections in their twenties were found in their thirties to have CD4+ lymphopenia and lymphocyte ADA activity of approximately 5% of the lower limit of normal. Immune function, measured by proliferation of PBMCs in vitro to mitogens and specific Ags, was impaired. Inheritance of a polymorphic marker showed that both patients were heterozygous at the ADA locus. In the paternal allele there was a deletion resulting from homologous recombination between two alu elements that normally flank the first exon and the polymorphic marker. The recombination site was distinct from that in similar deletions described in two infants having severe combined immunodeficiency. This allele is predicted to result in a null phenotype. In the mutant allele inherited from the mother, a C to T transition in a CpG dinucleotide changed the codon for arginine 211, which lies in a conserved sequence close to the active site, to that for cysteine. This mutation has been observed previously in a child in whom the other allele was also a null mutation, but who was diagnosed as having partial ADA deficiency because immune function was apparently normal. The late onset of immunodeficiency in our patients suggests that immune function in children with partial ADA deficiency may deteriorate with time and that ADA deficiency should be regarded as a possible cause of adult onset immune dysfunction of unknown etiology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

3.  Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association.

Authors:  Christina S Yee; Michel J Massaad; Wayne Bainter; Toshiro K Ohsumi; Niko Föger; Andrew C Chan; Nurten A Akarsu; Caner Aytekin; Deniz Çagdas Ayvaz; Ilhan Tezcan; Özden Sanal; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

Review 4.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

5.  Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.

Authors:  A Fleischman; M S Hershfield; S Toutain; H M Lederman; K E Sullivan; M B Fasano; J Greene; J A Winkelstein
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 6.  Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency.

Authors:  M S Hershfield; F X Arredondo-Vega; I Santisteban
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia.

Authors:  C L Shovlin; J M Hughes; J Scott; C E Seidman; J G Seidman
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

8.  Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1 mutation.

Authors:  Roshini S Abraham; Mike Recher; Silvia Giliani; Jolan E Walter; Yu Nee Lee; Francesco Frugoni; Daniel E Maddox; Salman Kirmani; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2012-11-02       Impact factor: 10.793

9.  Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare.

Authors:  T Trojan; R Collins; D A Khan
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

10.  Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.

Authors:  F X Arredondo-Vega; I Santisteban; S Daniels; S Toutain; M S Hershfield
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.